The use of typhoid vaccines in Asia: The DOMI experience

R. Leon Ochiai, Camilo J. Acosta, Magdarina Agtini, Sujit K. Bhattacharya, Zulfiqar A. Bhutta, Canh Gia Do, Baiqing Dong, Xinguang Chen, Bonita Stanton, Linda Kaljee, Andrew Nyamete, Claudia M. Galindo, Lorenz Von Seidlein, Denise DeRoeck, Luis Jodar, John D. Clemens

Research output: Contribution to journalReview articlepeer-review

36 Citations (Scopus)


Background. Two currently licensed typhoid vaccines have been evaluated in Asia, yet few Asian countries have considered including typhoid vaccines in their vaccination programs. The Diseases of the Most Impoverished (DOMI) Program was initiated to provide evidence to decide on the introduction of typhoid vaccines in Asian countries. Methods. The centerpiece of the program is a multidisciplinary demonstration project with Vi vaccine in 5 Asian countries. The project includes epidemiologic, economic, sociobehavioral, and policy studies. Results. Policy makers want evidence on which to base their vaccine-related decisions. The DOMI Program has provided updated information on the typhoid fever burden at several Asian sites. Cost-of-illness studies found high costs to governments and individuals. Sociobehavioral studies indicated a positive attitude toward typhoid vaccines. The results of the demonstration projects indicate that mass-immunization campaigns are feasible and acceptable. Conclusions. The DOMI Program has begun to provide momentum for the evidence-based, rational introduction of typhoid vaccines into the public health programs of several Asian countries.

Original languageEnglish
Pages (from-to)S34-S38
JournalClinical Infectious Diseases
Issue numberSUPPL. 1
Publication statusPublished - 15 Jul 2007


Dive into the research topics of 'The use of typhoid vaccines in Asia: The DOMI experience'. Together they form a unique fingerprint.

Cite this